AJMC Staff

The uptick in BMI among professional baseball players coincides with the steroid era, although there were also advances in nutrition and training that could explain weight gain.

Highlights of our peer-reviewed research in the healthcare and mainstream press.

What we're reading, September 29, 2016: as part of the bill to prevent a government shutdown, the Senate has finally approved Zika virus funding; electronic health record breaches skyrocketed from 2014 to 2015; and California passes "right to try" law for terminally ill patients.

What we're reading, September 28, 2016: a new company will help people fight their medical bills; prescription drug monitoring programs may not be helping the opioid crisis; and why banning pay-for-delay deals may not help to lower costs.

What we're reading, September 27, 2016: a panel of experts recommends expanding preventive services for women with no cost sharing; BlueCross BlueShield of Tennessee is exiting 3 Obamacare exchanges; and Pfizer will not split into 2 companies.

What we're reading, September 26, 2016: the obesity rate in America has been rising steadily, but the health system is ill equipped to treat these patients; the pros and cons of mail-order medications; and barring recipients of federal funding from preventing money from going to Planned Parenthood.

Our peer-reviewed research in the healthcare and mainstream press.

What we're reading, September 23, 2016: California's insurance commissioner wants to try a public option; Valeant avoids double-digit price hikes with 9.9% increases; maker of Suboxone being sued by 35 states and the District of Columbia for keeping generics off the market.

What we're reading, September 22, 2016: a new bill would cap out-of-pocket costs for Medicare beneficiaries; world leaders agreed to a global effort to curb the spread of superbugs; and Mark Zuckerberg and Priscilla Chan, MD, will donate $3 billion over 10 years to cure disease.

What we're reading, September 21, 2016: Missouri law to charge Medicaid patients for missed doctor's appointments is in limbo; generic drugs' potential to bring down costs; fitness trackers cause people to lose less weight.

What we're reading, September 20, 2016: CDC reports widespread use of powerful antibiotics in hospitals; Gilead Sciences is backing advocates who want states to pay for expensive drugs; and Zika travel advisory lifted in 1 Florida zone.

Using prophylaxis with biosimilar granulocyte colony-stimulating factor can reduce the severity of neutropenia in patients with soft tissue sarcoma.

What we're reading, September 19, 2016: the government update rules on reporting clinical trial findings; hospitals say they aren't receiving discounts for Valeant's heart drugs; and the FDA approved the first treatment for Duchenne muscular dystrophy.

Highlights of our peer-reviewed research in the healthcare and mainstream press.

What we're reading, September 16, 2016: Donald Trump mentions using Medicaid to expand coverage and making birth control available without a prescription; medical marijuana could curb the opioid epidemic; and how rare diseases are becoming more common.

What we're reading, September 15, 2016: A United Nations panel challenges the market-based approach to drug research and development; an FDA panel recommends removing a serious health warning from Chantix's label; and older patients may want to wait to get their flu shot.

What we're reading, September 14, 2016: CMS denies Ohio's proposal to charge Medicaid fees; steep costs of healthcare continue to push Americans into poverty; and Canada approves prescription heroin to treat severe addiction.

Although daratumumab reduced the risk of disease progression and death for patients with multiple myeloma, the drug was associated with a higher rate of neutropenia.

What we're reading, September 13, 2016: GOP bill would exempt people who live in areas with 1 Obamacare plan or none from penalties for not having coverage; hepatitis C drugs threaten to bust prison budgets; and school challenges for children with mental illness.

FDA staff are not convinced that the smoking-cessation drugs varenicline (Chantix), developed by Pfizer, and bupropion (Zyban), developed by GSK, do not increase suicidal tendencies among users.

What we're reading, September 12, 2016: Hillary Clinton's health is being called into question as her campaign confirms she has pneumonia; responders who helped during the 9/11 terrorist attacks may be sick and not know it; and Sanofi and Google team up for a diabetes venture.

Highlights of our peer-reviewed research in the healthcare press.

What we're reading, September 9, 2016: Walgreens believes it may need to unload more stores to ease antitrust concerns over its Rite Aid purchase; the Senate may be nearing a Zika funding agreement; and American dissatisfaction with their healthcare system.

What we're reading, September 8, 2016: An Arizona county at risk of having no Affordable Care Act plans in 2017 gains an insurer; the difficulty of obtaining medical records; and Ohio county offers immunity for anyone turning in deadly drugs.

What we're reading, September 7, 2016: Allergan vows to limit drug price hikes; Senate votes again to block Zika funding bill; and CMS will institute a new process to screen people signing up for Obamacare coverage during special enrollment periods.

What we're reading, September 6, 2016: state prescription databases play a role in fighting the opioid epidemic; experimenting with transition models to reduce gaps in care; and how electronic health records slow down doctors.

What we're reading, September 5, 2016: Zika virus remains a global health emergency and worsens in Asia; the government provides "simple choice plan" options for 2017's open enrollment season; and how hospitals are improving the workplace.

Highlights of our peer-reviewed research in the healthcare and maintstream press.

What we're reading, September 2, 2016: California taxpayers will cover 70% of the state's healthcare costs in 2016; President Barack Obama supports recommendations to reform the Veterans Affairs healthcare system; and California is close to criminalizing undercover stings against Planned Parenthood.

What we're reading, August 31, 2016: 51% of Americans have a negative view of the pharmaceutical industry; the CDC is running out of funds to fight the Zika virus; and Pennsylvania chooses 3 private companies to manage Medicaid plans.